Sponsor

MedDay Pharmaceuticals SA

Clinical research sponsor

Published trials4
Recruiting shown0
Roles2
SourceClinicalTrials.gov

Clinical trials

4 shown
Effect of MD1003 in Progressive Multiple Sclerosis (SPI2)NCT02936037 · lead sponsor · 2016-12-01
TERMINATED
Effect of MD1003 in Chronic Visual Loss Related to Optic Neuritis in Multiple SclerosisNCT02220244 · lead sponsor · 2013-10-01
UNKNOWN
Effect of MD1003 in Spinal Progressive Multiple SclerosisNCT02220933 · lead sponsor · 2013-10-01
UNKNOWN
Evaluation of the Incidence of Relapses in Patients With Biotin-treated Progressive Multiple SclerosisNCT03552211 · collaborator · 2018-05-30
UNKNOWN

Sponsor roles

lead sponsor3
collaborator1

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.